Abstract:
Objective To investigate the prognostic significance of high sensitivity-C reactive protein (Hs-CRP) in patients with peripheral T-cell lymphoma (PTCL).
Methods A total of 234 newly diagnosed PTCL patients with a median age of 48 years were analyzed retrospectively. Serum Hs-CRP levels and other factors, including tumor stage and international prognostic index (IPI), were determined. After a median follow-up of 23 months, the relationship between Hs-CRP and overall survival (OS) was observed.
Results Serum Hs-CRP level positively correlated with IPI score (r=0.132, P < 0.001), tumor stage (r=0.183, P=0.005), B symptoms (r=0.225, P=0.001), and lactic dehydrogenase (r=0.169, P=0.009), but negatively correlated with plasma albumin levels (r=-0.343, P < 0.001), hemoglobin concentration (r=-0.239, P < 0.001), and platelet count (r=0.131, P=0.045), and is uncorrelated with age (P>0.05), gender (P>0.05), fitness score (P>0.05), and leukocyte count (P>0.05). Patients with serum Hs-CRP levels ≤10 mg/L had better OS than patients with serum Hs-CRP levels>10 mg/L. Univariate and multivariate Cox regression models showed that platelet count, Hs-CRP, albumin levels, and IPI score were independent adverse prognostic factors.
Conclusion The baseline Hs-CRP level can serve as a major indicator of prognosis in PTCL patients.